What the COPD evidence supports
01 / Established benefit
Exacerbation benefit in all three trials.¹ ² ³
02 / Differentiation
The endpoint profiles differ. The separate trials do not establish head-to-head superiority.
Delegate research and get finished work.
Give your team more capacity to investigate opportunities. Maven works from connected biopharma evidence, checks claims, and produces files in your team’s templates.
Inspect the evidence behind the assessment.
Review drug comparisons and publication findings alongside the source passages that support them, with built-in fact checking.
COPD competitive assessment
Smart Table
Research questions answered for each drug
| Drug | Which outcomes improved? | What limits the claim? |
|---|---|---|
| DupilumabIL-4Rα antibody | Fewer exacerbations and better lung function. BOREAS · NOTUS 1, 2 | Quality-of-life findings differ between the two trials. Trial-specific findings |
| MepolizumabIL-5 antibody | Fewer exacerbations and a longer time to the first event. MATINEE 3 | No significant quality-of-life or symptom benefit. MATINEE 3 |
Create sourced files in your team’s templates.
Build and iterate on PowerPoint presentations, Excel workbooks, Word reports, and charts in your Maven project.
Xcopd_evidence.xlsx
C1ƒxRate ratio (95% CI)
| A | B | C | |
|---|---|---|---|
| 1 | Study | Therapy | Rate ratio (95% CI) |
| 2 | BOREAS | Dupilumab | 0.70 (0.58–0.86) |
| 3 | NOTUS | Dupilumab | 0.66 (0.54–0.82) |
| 4 | MATINEE | Mepolizumab | 0.79 (0.66–0.94) |
Trial comparisonPopulationsSources
Exacerbation benefit within each trial
Rate ratio vs placebo · 95% CIBOREAS
0.70
NOTUS
0.66
MATINEE
0.79
0.500.751.00
Separate placebo-controlled trials, not a head-to-head comparison.
Wcopd_assessment.docx
Guide the agent as the research develops.
Speak or type the brief, tag entities or research items, attach files, and change the instructions while Maven works.
- Answer
- A focused response to your question.
- Plan
- An approach to review before the work begins.
- Work
- The investigation and its finished deliverables.
Use automatic model routing or choose among frontier models for the task.
Compare the COPD trial evidence and prepare a competitive briefing in this template.
Work modeModel routing: Auto
Comparing study populations and outcomes
Your direction
“Prioritize exacerbations and lung function. Keep indirect comparisons separate.”
I’ll separate the trial results from comparative claims and carry that distinction into the review.
Make the next assignment repeatable.
Reuse your research method and deliverable format with a workflow that runs on demand or on a schedule.
Explore workflows →Keep the finished work current.
Select files in your Maven project for monitoring. Maven can apply sourced edits as evidence changes. Review the edit history, roll back changes, and download the current files.
Explore monitoring →